1-5 of 5
Fevzi Yalniz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience

Omur Gokmen Sevindik, MD, Mustafa Pehlivan, MD, Tulin F Tuglular, MD, Serife M Solmaz, MD, Mehmet Hilmi Dogu, Fevzi Yalniz, MD, Ali Ugur Ural, MD, Zafer Serenli Yeğen, MD, Mutlu Arat, MD, Vildan Ozkocaman, MD, Elif G Umit, MD, Handan Haydaroğlu Şahin, MD, Mehmet Sönmez, MD, Mehmet Turgut, MD, Muhit Ozcan, MD, Onder Arslan, MD, Yildiz Aydin, MD, Tayfun Elibol, MD, Aybuke Harmandali Olgun, MD, Banu Bayar, MD, Anil Tombak, MD, Ismet Aydogdu, MD, Güner Hayri Özsan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5405.
https://doi.org/10.1182/blood.V130.Suppl_1.5405.5405
Published: 2017
Journal Articles

Prognostic Factors and Survival Outcomes in Blast Transformed Chronic Myelomonocytic Leukemia: A Mayo Clinic-MD Anderson Cancer Center Study of 171 Cases

Mrinal M. Patnaik, MDMBBS, Ana Alfonso, MD, Fevzi Yalniz, MD, Tapan M. Kadia, MD, Rangit Vallapureddy, MBBS, Elias Jabbour, MD, Terra L. Lasho, PhD, Curtis A. Hanson, MD, Hagop M. Kantarjian, MD, Ayalew Tefferi, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2964.
https://doi.org/10.1182/blood.V130.Suppl_1.2964.2964
Published: 2017
Journal Articles

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia (CMML) Patients Treated with Hypomethylating Agents. a Report on 183 Patients

Matthieu Duchmann, Fevzi Yalniz, MD, Alessandro Sanna, David A Sallman, MD, Catherine C. Coombs, MD, Aline Renneville, MDPhD, Olivier Kosmider, Thorsten Braun, MD PhD, Uwe Platzbecker, MD, Lise Willems, MD, Lionel Ades, MD PhD, Michaela Fontenay, MD PhD, Raajit K. Rampal, MD PhD, Eric Padron, MD, Nathalie Droin, Claude Preudhomme, PharmD, PhD, Valeria Santini, MD, Mrinal M. Patnaik, MDMBBS, Pierre Fenaux, MD PhD, Éric Solary, MD PhD, Raphael Itzykson, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 159.
https://doi.org/10.1182/blood.V130.Suppl_1.159.159
Published: 2017
Journal Articles

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Fevzi Yalniz, MD, Mehrdad Hefazi, MD, Kristen B. McCullough, PharmD, Mark Litzow, MD, William J Hogan, MBChB, Robert C Wolf, PharmD, Hassan B Alkhateeb, MD, Ankit Kansagra, Moussab Damlaj, MD, Mrinal M Patnaik, MBBS
Journal: Blood
Blood (2016) 128 (22): 4593.
https://doi.org/10.1182/blood.V128.22.4593.4593
Published: 2016
Journal Articles

Feasibility of Allogeneic Hematopoietic Stem Cell Transplant for High Risk FLT3-ITD Mutant Patients with Acute Myeloid Leukemia in CR1- a Real Word Analysis

Ankit J. Kansagra, MD, Hassan B Alkhateeb, MD, Mehrdad Hefazi, MD, Fevzi Yalniz, MD, William J Hogan, MD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS
Journal: Blood
Blood (2016) 128 (22): 4694.
https://doi.org/10.1182/blood.V128.22.4694.4694
Published: 2016